1.
The Belgian MIRA (MabThera In Rheumatoid Arthritis) registry : clues for the optimization of rituximab treatment strategies.
2.
3.
4.
5.
6.
7.
8.
9.
The epidemiology of ankylosing spondylitis and the commencement of anti-TNF therapy in daily rheumatology practice.